DRY POWDER INHALERS - ADVANTAGES AND LIMITATIONS

被引:51
作者
CROMPTON, GK
机构
[1] Northern General Hospital, Edinburgh, Scotland, Ferry Road
来源
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG | 1991年 / 4卷 / 03期
关键词
NEW INHALERS; DRY POWDER INHALERS TURBUHALER; DISKHALER; INSPIRATORY FLOWS;
D O I
10.1089/jam.1991.4.151
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
New inhalers have been developed because of difficulty of using the conventional metered dose inhaler (MDI) and because of the impending ban on CFC's. Dry powder inhalers (DPI's) in general are easier to use than the MDI and cause fewer irritant effects. Unlike the MDI few patients develop a poor inhalation technique with continued use of DPI's. Comparisons of multidose DPI's have shown that they achieve a similar degree of bronchodilatation to the MDI. Comparisons of the Diskhaler and Turbuhaler have shown little difference in therapeutic efficacy, but most indicate patient preference for the Turbuhaler. The inspiratory flow necessary to achieve a therapeutic effect is critical with DPI's. The majority of patients with severe acute asthma can achieve a peak inspiratory flow sufficient to inhale a bronchodilator from a Turbuhaler. DPI's cannot be used with spacers; this may be a disadvantage in patients who inhale large doses of steroids. © 1991, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 26 条
[1]  
PATERSON I.C., CROMPTON G.K., Use of pressurised aerosols by asthmatic patients, Br Med J., 1, pp. 76-77, (1976)
[2]  
OREHEK J., GAYRARD P., GRIMAUD C., CHARPIN J., Patient error in use of bronchoddlator metered aerosols, Br Med J., 1, (1976)
[3]  
CROMPTON G.K., Problems patients have using pressurised aerosols, Eur J Respir Dis., 63, pp. 101-104, (1982)
[4]  
EPSTEIN S.W., MANNING G.P.R., ASHLEY M.J., COREY P.M., Survey of clinical use of pressurised aerosol inhalers, Can Med Assoc J., 120, pp. 813-816, (1976)
[5]  
NEWMAN S.P., Metered dose pressurised aerosols and the ozone layer, Eur Respir J., 3, pp. 495-497, (1990)
[6]  
DUNCAN D., PATERSON I.C., HARRIS D., CROMPTON G.K., Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional aerosol, Br J Clin Pharmacol., 4, pp. 669-671, (1977)
[7]  
CROMPTON G.K., DUNCAN J., Clinical assessment of a new breath-actuated inhaler, Practitioner., 233, pp. 268-269, (1989)
[8]  
CROMPTON G.K., The role of inhaled beta-agonists and different delivery systems in asthma, In: A new concept in inhalation therapy, pp. 71-75, (1987)
[9]  
DUNCAN J., NING A.C.W.S., CROMPTON G.K., Clinical assessment of a new multidose nonpressurised metered-dose inhaler, Drug Invest, 2, pp. 136-137, (1990)
[10]  
Glaxo